News UK MHRA authorises orforglipron private prescription Eli Lilly has announced that orforglipron (Foundayo) is now available to be prescribed for eligible adults via private prescription.
News NVIDIA announces Lilly, Thermo Fisher collaborations at JPM Global chipmaker giant NVIDIA kicked off JPM Week with several partnership announcements, including a billion dollar partnership with Eli Lilly.
Market Access Capping the cost of insulin: altruistic or strategic? The price of insulin has become one of the most talked about issues across the pharma industry.
News Lilly shares disappointing A4 study results for solanezumab The drug only targets soluble amyloid beta-protein and doesn't clear amyloid plaques.
News Lilly slashes insulin price 70%, patient cost cap now $35 Lilly trying to make it easier for patients to access its insulin and help Americans generally.
R&D Almirall/Lilly lebrikizumab offers potential long-term manag... Atopic dermatitis (AD) is a highly prevalent chronic dermatological disease, with symptoms which include itching, dry skin, severe pain, and inflammation – all of which create considerable
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
